Medication-related clinical decision support alert overrides in inpatients
Medication-related clinical decision support alert overrides in inpatients
复制标题
DOI：
10.1093/jamia/ocx115
复制
发表时间：
2018-05-01
影响因子：
6.4
通讯作者：
WBates, David
中科院分区：
文献类型：
--
作者：
Nanji, Karen C.;Seger, Diane L.;WBates, David
目的：定义住院患者临床决策支持警报的类型和数量，测量它们被覆盖的频率，并描述提供者覆盖它们的原因和这些原因的适当性。材料和方法：我们在一家拥有793张床位的三级护理教学机构进行了一项为期3年的药物相关临床决策支持警报的横断面研究。我们测量了警报覆盖的频率、按警报类型划分的覆盖频率、覆盖的原因以及这些原因的适当性。结果：总体而言，73.3%的患者过敏、药物-药物相互作用和重复药物警报被覆盖，尽管覆盖率因警报类型而异(P
Objective: To define the types and numbers of inpatient clinical decision support alerts, measure the frequency with which they are overridden, and describe providers' reasons for overriding them and the appropriateness of those reasons.Materials and Methods: We conducted a cross-sectional study of medication-related clinical decision support alerts over a 3-year period at a 793-bed tertiary-care teaching institution. We measured the rate of alert overrides, the rate of overrides by alert type, the reasons cited for overrides, and the appropriateness of those reasons.Results: Overall, 73.3% of patient allergy, drug-drug interaction, and duplicate drug alerts were overridden, though the rate of overrides varied by alert type (P